Awareness of dysphagia by patients following stroke predicts swallowing performance

Parker, Claire; Power, Maxine; Hamdy, Shaheen; Bowen, Audrey; Tyrrell, Pippa; Thompson, David G.
January 2004
Dysphagia (0179051X);Jan2004, Vol. 19 Issue 1, p28
Academic Journal
journal article
Patients' awareness of their disability after stroke represents an important aspect of functional recovery. Our study aimed to assess whether patient awareness of the clinical indicators of dysphagia, used routinely in clinical assessment, related to an appreciation of "a swallowing problem" and how this awareness influenced swallowing performance and outcome in dysphagic stroke patients. Seventy patients were studied 72 h post hemispheric stroke. Patients were screened for dysphagia by clinical assessment, followed by a timed water swallow test to examine swallowing performance. Patient awareness of dysphagia and its significance were determined by detailed question-based assessment. Medical records were examined at three months. Dysphagia was identified in 27 patients, 16 of whom had poor awareness of their dysphagic symptoms. Dysphagic patients with poor awareness drank water more quickly (5 ml/s vs. <1 ml/s, p = 0.03) and took larger volumes per swallow (10 ml vs. 6 ml, p = 0.04) than patients with good awareness. By comparison, neither patients with good awareness or poor awareness perceived they had a swallowing problem. Patients with poor awareness experienced numerically more complications at three months. Stroke patients with good awareness of the clinical indicators of dysphagia modify the way they drink by taking smaller volumes per swallow and drink more slowly than those with poor awareness. Dysphagic stroke patients, regardless of good or poor awareness of the clinical indicators of dysphagia, rarely perceive they have a swallowing problem. These findings may have implications for longer-term outcome, patient compliance, and treatment of dysphagia after stroke.


Related Articles

  • THE ROLE OF EDUCATION ON BEHAVIORAL CHANGES TO MODIFIABLE RISKS FACTORS AFTER MYOCARDIAL INFARCTION. Marvaki, Christina; Argyriou, G.; Karkouli, G.; Kossivas, P.; Marvaki, A.; Pilatis, N.; Polikandrioti, M.; Dimoula, Y. // Health Science Journal;2007, Issue 3, p1 

    Myocardial infarction (MI) is the condition of irreversible necrosis of the heart muscle that results from prolonged ischemia. After World War II coronary heart disease (CHD) assumed epidemic proportions in western countries, nowadays, myocardial infarction is the leading cause of death in...

  • RED FLAGS.  // Natural Health;Feb2012, Vol. 42 Issue 2, p78 

    The article focuses on the symptoms of heart attack in women which include cold sweats, shortness of breath, and dizziness.

  • ASK THE DOC HOW DOES heart DISEASE DIFFER FOR WOMEN? Barnard, Neal // Vegetarian Times;Feb2007, Issue 347, p18 

    The article presents questions and answers related to heart attack. One person asked whether symptoms of heart attacks for men and women are different. The answer was that women are at special risk when they have heart attacks because their symptoms are often deceptively mild, such as shortness...

  • WARNING SIGNS DIFFER IN WOMEN.  // USA Today Magazine;Feb2004, Vol. 132 Issue 2705, p16 

    Focuses on the symptoms of heart attack in women. Most important symptom of heart attack for both women and men; Importance of early recognition of signs of heart attack; Major prodromal symptoms of heart attack.

  • Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes. Blackman, D. J.; Clarke, N. R.; Orr, W. P.; Wilkinson, E.; Beswick, A.; Coppock, D.; Sprigings, D. C.; Banning, A. P. // Heart;Apr2002, Vol. 87 Issue 4, p375 

    This article focuses on a study related to the day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes. Early revascularization improves outcome in patients with non-ST elevation acute coronary syndromes (ACS), particularly if they are...

  • NICE guidance on clopidogrel.  // GP: General Practitioner;5/10/2004, p12 

    Draft guidance on the use of clopidogrel (Plavix) in the management of non-ST segment elevation acute coronary syndrome (ACS) has been issued by NICE. It recommends the use of clopidogrel, in combination with low-dose aspirin, for patients who have non-ST segment elevation ACS and have a...

  • The Language of the Heart. Agatston, Arthur // Prevention;May2008, Vol. 60 Issue 5, p39 

    The author reports on the symptoms patients feel when having a heart attack. According to the article, symptoms which people should be concerned about include persistent chest pain, varied shortness of breath and unusual upper-body pain. Steps which people can take to learn if the pain they are...

  • Risk stratification in acute coronary syndrome: bus on unstable angina/non-ST segment elevation myocardial infarction. Bugiardini, R. // Heart;Jul2004, Vol. 90 Issue 7, p729 

    Although there have been advances in the management of unstable angina/non-ST segment elevation myocardial infarction syndromes, the rate of cardiovascular mortality after discharge is still unacceptably high. With many therapeutic options available, the clinician is challenged to identify the...

  • CLINICAL ASSESSMENT OF MYOCARDIAL HIBERNATION. Schinkel, Arend F. L.; Bax, Jeroen J.; Poldermans, Don // Heart;Jan2005, Vol. 91 Issue 1, p111 

    The article focuses on the clinical importance and identification of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Coronary artery disease is the most common cause of congestive heart failure. More than 70% of the patients with heart failure symptoms have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics